You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Arvelle Therapeutics International GmbH (Add-on Acquistion, in 2021)

Transaction #134287
Investor
1
Sign up to view
Target Company
Arvelle Therapeutics International GmbH
Life Science · Switzerland
Seller
1
Sign up to view
960 USD
Deal Value
05 Jan 2021
Announced
Target Company
Company Sector Entity Type Status State Country
Arvelle Therapeutics International GmbH Life Science Private Active — Switzerland
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Arvelle Therapeutics International GmbH acquisition deal?
This transaction is an acquisition of Arvelle Therapeutics International GmbH (Add-on Acquistion) in 2021. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Arvelle Therapeutics International GmbH acquisition happen?
This transaction was announced on 05 Jan 2021.
What is the deal value of the Arvelle Therapeutics International GmbH acquisition?
The deal value for this transaction is 960 USD.
Who are the investors in the Arvelle Therapeutics International GmbH transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Arvelle Therapeutics International GmbH deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial